MedPath

ALPHAGAN

ALPHAGAN

Approved
DIN Number

02236876

Drug Class

Human

Market Date

Dec 2, 1997

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02236876
AIG Number0131859001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EA05 BRIMONIDINE
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:40.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

BRIMONIDINE TARTRATEActive
Strength: 0.2 % / W/V
Monograph: BRIMONIDINE TARTRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.